Home > Insider Trading > Filing (0001127602-14-015509)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318154	Amgen Inc	AMGN	Biological Products, (No Disgnostic Substances) (2836)	953540776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1335311	Kelly A Michael	One Amgen Center Drive Thousand Oaks CA 91320-1799	Acting Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-04-25	174	$113.72	42,740	No	4	F	Direct
Common Stock	Acquisiton	2014-04-25	628	$0.00	43,368	No	4	A	Direct
Common Stock	Disposition	2014-04-26	116	$111.41	43,252	No	4	F	Direct
Common Stock	Disposition	2014-04-27	140	$111.41	43,112	No	4	F	Direct
Common Stock	Disposition	2014-04-27	6	$111.41	43,106	No	4	F	Direct
Common Stock	Disposition	2014-04-28	2,065	$110.45	41,041	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	183	Indirect	401(k) Plan

Footnotes

The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2017.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 508 RSUs which vest in one installment on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 780 RSUs which vest in two equal installments of 257 each on 4/26/2015 and 4/26/2016 and one installment of 266 on 4/27/2017; 8,406 RSUs which vest in two equal installments of 4,203 each on 6/30/2014 and 6/30/2015; and 628 RSUs which vest in two equal installments of 207 each on 4/25/2016 and 4/25/2017 and one installment of 214 on 4/25/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 87 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share interest.
These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.